Beta Blockade and the Heart - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Beta Blockade and the Heart

Description:

Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology Beta Blocker Heart Attack Trial Randomized 4000 Patients ... – PowerPoint PPT presentation

Number of Views:120
Avg rating:3.0/5.0
Slides: 15
Provided by: G8
Category:
Tags: beta | blockade | blocker | heart

less

Transcript and Presenter's Notes

Title: Beta Blockade and the Heart


1
Beta Blockade and the Heart
  • John Hakim, M.D
  • Cardiology Fellow
  • West Virginia University
  • Division of Cardiology

2
Beta Blocker Heart Attack Trial
  • Randomized 4000 Patients to Placebo Vs.
    Propranolol
  • 20 Reduction in Mortality in Propranolol group
  • Despite a 17 rise in Triglycerides and a 6 rise
    in LDL

3
Beta Blockers in ACUTE MI
  • Beta Blockers Reduce pain, and reduce need for
    analgesics presumably by reducing ischemia
  • Most useful in patients with sinus tachycardia
    and HTN post MI

4
Beta Blockers in ACUTE MIProtocol (Braunwald)
  • Exclude patients with Heart Failure (10 cm rales
    above diaphragm), hypotension lt90mmHG,
    Bradycardia lt60 bpm, and Heart Block.
  • Metoprolol in three 5mg boluses q 5 min
  • Stop if HR lt60 or SBP lt100mmHg
  • If stable, give oral metoprolol 50mg q6h x 2 days
  • Then switch to 100mg BID or Toprol XL (IV
    esmolol useful in patient with relative
    contraindication.)

5
What not to give Post Acute MI
  • Unlike Beta Blockers, calcium antagonists are of
    little value in AMI and may, in fact, be
    hazardous.

6
Effects of Beta Blockers Post MI
  • Immediate reduces cardiac index, heart rate and
    blood pressure. Net effect is to reduce
    myocardial oxygen consumption/minute/beat.
    (Reduces Chest Pain)
  • Reduces infarct Size in Acute MI
  • Diminishes circulating levels of free fatty acids
    by antagonizing lipolytic effects of
    catecholamines. (FFA augment O2 consumption and
    increases incidence of arryhthmias.

7
Effects of Beta Blockers Post MI(Pre-Thrombolytic
Era)
  • ISIS-1
  • 16,000 patients randomized
  • reduction of mortality among patients randomized
    to IV atenolol Vs. placebo.
  • Meta analysis of 27 trials (27,000 patients) IV
    followed by oral beta blockers
  • 15 relative reduction in mortality, non fatal
    reinfarction, and nonfatal cardiac arrest

8
Effects of Beta Blockers Post MI
  • TIMI-II trial (Thrombolytics in MI)
  • Recurrent ischemia and reinfarction were reduced
    by immediate vs. delayed use of metoprolol.
  • mortality and LV function were not improved by
    immediate metoprolol.
  • Therefore beta-blockers are beneficial, but may
    not enhance the salvage of myocardium due to
    early reperfusion.

9
Effects of Beta Blockers Post MICurrent
Recommendations
  • Patients with hyperdynamic state ( sinus
    tachycardia, HTN, no CHF or bronchospasm, no
    heart block)
  • Patients seen in the first 4 hours of their MI
  • Regardless of whether thrombolytics are used
  • Beta-Blockers indicated for people with
    persistent or recurrent ischemic pain

10
Beta Blockers and Idiopathic Dilated
Cardiomyopathy
  • Chronic Beta-Blockers increase the number of Beta
    adrenergic receptors on the Heart
  • Reduced ischemia and more efficient oxygen
    utilization (Study done w/ metoprolol)
  • Detectable improvement in Cardiac Output (and EF)
    after three months.
  • Long term structural changes of decline in LV
    volume and Mass after 12-18 months.

11
Other Beta Blocker Indications
  • Arrhythmias associated withthyrotoxicosis,
    pheochromocytoma
  • excess catecholamine state.
  • Arrhythmias initiated by excercise or emotion
    often respond to propranolol
  • Metoprolol may be helpful in controlling rate of
    multifocal atrial tachycardia

12
Question
  • Peri-operative myocardial ischemia is the single
    most important reversible risk factor for
    mortality and cardiovascular complications
    annually.
  • Is there any way to prevent perioperative
    myocardial ischemia during non cardiac therapy?

13
Perioperative Cardiovascular Morbidity and
Mortality
  • In patients who are at risk for coronary artery
    disease who must undergo non-cardiac surgery,
    treatment with atenolol during hospitalization
    can reduce mortality and the incidence of
    cardiovascular complications for as long as 2
    years after surgery. (N Eng J Med
    19963351713-20)

14
Perioperative Cardiovascular Morbidity and
Mortality
  • In patients with CAD standard practice is to
    control heart rate pre-op and intra-op.
  • Post-op tachycardia may precipitate ischemia
  • Beta-blockade can modulate the post-op
    sympathetic response.
  • Preventing ischemia prevents morbidity and
    mortality.
Write a Comment
User Comments (0)
About PowerShow.com